Oncology Institute, Inc. (TOI) FCF Margin (2021 - 2026)
Oncology Institute's (TOI) quarterly FCF Margin came in at 1.51% in Q1 2026, up 327.0% YoY from 0.35% in Q1 2025, and down 7253.64% on a QoQ basis from 0.02% in Q4 2025.
Oncology Institute, Inc. (TOI) FCF Margin (2021 - 2026) Analysis & Trends
Oncology Institute (TOI) has 6 years of FCF Margin data on file, last reported at 1.51% in Q1 2026.
- Quarterly FCF Margin rose 327.0% year-over-year to 1.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.59% (up 13.0% YoY) and the FY2025 annual result came in at 5.53%, up 218.0% from the prior year.
- FCF Margin slipped to 1.51% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 0.81% in Q3 2024 to a low of 32.6% in Q1 2022.
- A 5-year average of 12.28% and a median of 9.8% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 3348 bps — and 2023, when it jumped 2260 bps.
- Tracing TOI's FCF Margin over 5 years: stood at 27.14% in 2022, then jumped by 83 bps to 4.54% in 2023, then jumped by 105 bps to 0.24% in 2024, then plunged by 91 bps to 0.02% in 2025, then tumbled by 7254 bps to 1.51% in 2026.
- The last three FCF Margin figures came in at 1.51% (Q1 2026), 0.02% (Q4 2025), and 8.12% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.84% |
| Mar 31, 2026 | -1.51% |
| Dec 31, 2025 | 0.02% |
| Sep 30, 2025 | -8.12% |
| Jun 30, 2025 | -9.80% |
| Mar 31, 2025 | -4.78% |
| Dec 31, 2024 | 0.24% |
| Sep 30, 2024 | 0.81% |
| Jun 30, 2024 | -15.29% |
| Mar 31, 2024 | -17.42% |
| Dec 31, 2023 | -4.54% |
| Sep 30, 2023 | -10.13% |
| Jun 30, 2023 | -8.60% |
| Mar 31, 2023 | -22.69% |
| Dec 31, 2022 | -27.14% |
| Sep 30, 2022 | -28.00% |
| Jun 30, 2022 | -19.24% |
| Mar 31, 2022 | -32.60% |
| Dec 31, 2021 | -46.28% |
| Sep 30, 2021 | -6.94% |